{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:41:39Z","timestamp":1782366099984,"version":"3.54.5"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jconrel.2023.09.023","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:07:41Z","timestamp":1696406861000},"page":"435-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer"],"prefix":"10.1016","volume":"363","author":[{"given":"Lara Scheherazade","family":"Milane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Dolare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.09.023_bb0005","author":"Society"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0010","author":"Organization, W. H"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0020","author":"NCI"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0025","author":"NCI"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0030","series-title":"Nanomedicine for Inflammatory Diseases","first-page":"319","article-title":"Ch. Chapter 9","author":"Milane","year":"2017"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP\u2013dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0050","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0055","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11033-021-06155-w","article-title":"ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine","volume":"48","author":"Juan-Carlos","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0065","doi-asserted-by":"crossref","first-page":"102422","DOI":"10.1016\/j.nano.2021.102422","article-title":"Mitochondrial nanomedicine: subcellular organelle-specific delivery of molecular medicines","volume":"37","author":"Milane","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104309119","article-title":"A role for endoplasmic reticulum dynamics in the cellular distribution of microtubules","volume":"119","author":"Tikhomirova","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0075","doi-asserted-by":"crossref","first-page":"627700","DOI":"10.3389\/fcell.2021.627700","article-title":"Endoplasmic reticulum-plasma membrane contact sites: regulators, mechanisms, and physiological functions","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2008.12.001","article-title":"Mitochondrial dynamics and cancer","volume":"19","author":"Grandemange","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317698391","article-title":"Mitochondrial dynamics and cancer","volume":"39","author":"Maycotte","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41419-017-0023-6","article-title":"Mitofusin 2: from functions to disease","volume":"9","author":"Filadi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0095","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/eci.12135","article-title":"Keeping mitochondria in shape: a matter of life and death","volume":"43","author":"Scorrano","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbamcr.2011.01.021","article-title":"Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission","volume":"1813","author":"Landes","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molcel.2014.10.028","article-title":"Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis","volume":"57","author":"Renault","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2007.06.026","article-title":"Mitochondrial fusion protects against neurodegeneration in the cerebellum","volume":"130","author":"Chen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.cdd.4402046","article-title":"Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons","volume":"14","author":"Yuan","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0125","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1083\/jcb.200209124","article-title":"Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis","volume":"159","author":"Karbowski","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0130","doi-asserted-by":"crossref","first-page":"25060","DOI":"10.1074\/jbc.M501599200","article-title":"Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization","volume":"280","author":"Neuspiel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1534-5807(01)00055-7","article-title":"The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis","volume":"1","author":"Frank","year":"2001","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.18632\/oncoscience.63","article-title":"Targeting protein synthesis in cancer cells","volume":"1","author":"Martineau","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.gde.2017.11.003","article-title":"Cross-talk between protein synthesis, energy metabolism and autophagy in cancer","volume":"48","author":"Lindqvist","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0150","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1158\/0008-5472.CAN-08-0074","article-title":"Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis","volume":"68","author":"Pervin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/156652413804810781","article-title":"Cell death and survival through the endoplasmic reticulum-mitochondrial axis","volume":"13","author":"Bravo-Sagua","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature07534","article-title":"Mitofusin 2 tethers endoplasmic reticulum to mitochondria","volume":"456","author":"de Brito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41419-017-0237-7","article-title":"The role of the mitochondria and the endoplasmic reticulum contact sites in the development of the immune responses","volume":"9","author":"Martinvalet","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0170","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1073\/pnas.1606786113","article-title":"Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum\u2013mitochondria tether","volume":"113","author":"Naon","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0327s68","article-title":"Isolation of endoplasmic reticulum, mitochondria, and mitochondria-associated membrane and detergent resistant membrane Fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts","volume":"68","author":"Williamson","year":"2015","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-12-407704-1.00005-1","article-title":"Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration","volume":"301","author":"Bravo","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/cancers10100344","article-title":"The unfolded protein response in breast cancer","volume":"10","author":"McGrath","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","article-title":"Measuring ER stress and the unfolded protein response using mammalian tissue culture system","volume":"490","author":"Oslowski","year":"2011","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.04.008","article-title":"The endoplasmic reticulum stress\/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma","volume":"118","author":"Pe\u00f1aranda Fajardo","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules201219865","article-title":"Unfolded protein response and macroautophagy in Alzheimer\u2019s, Parkinson\u2019s and Prion diseases","volume":"20","author":"Milisav","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0205","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1242\/jcs.080762","article-title":"Increased ER\u2013mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress","volume":"124","author":"Bravo","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0210","series-title":"International Review of Cell and Molecular Biology","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-12-407704-1.00005-1","volume":"vol. 301","author":"Bravo","year":"2013"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0215","doi-asserted-by":"crossref","first-page":"104702","DOI":"10.1016\/j.phrs.2020.104702","article-title":"Endoplasmic reticulum stress signaling in cancer and neurodegenerative disorders: tools and strategies to understand its complexity","volume":"155","author":"da Silva","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0220","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nchembio.995","article-title":"Direct and selective small-molecule activation of proapoptotic BAX","volume":"8","author":"Gavathiotis","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0225","article-title":"Neoadjuvant treatment for triple negative breast cancer: recent progresses and challenges","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0230","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-021-00911-y","article-title":"Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine","author":"Milane","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0250","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.03.036","article-title":"Mitochondrial biology, targets, and drug delivery","volume":"207","author":"Milane","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11095-010-0173-z","article-title":"Nanoparticles: a promising modality in the treatment of sarcomas","volume":"28","author":"Susa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0260","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0265","series-title":"SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness","author":"Corbett","year":"2020"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0270","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0280","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1056\/NEJMcibr2009737","article-title":"Amplifying RNA vaccine development","volume":"382","author":"Fuller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0285","doi-asserted-by":"crossref","first-page":"107247","DOI":"10.1016\/j.intimp.2020.107247","article-title":"COVID-19 and cancer: from basic mechanisms to vaccine development using nanotechnology","volume":"90","author":"Han","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0290","article-title":"SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies","author":"Huang","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0295","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","author":"Kim","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0305","article-title":"The current status of COVID-19 vaccines","volume":"2","author":"Lundstrom","year":"2020","journal-title":"Front. Genome Edit."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nantod.2019.02.005","article-title":"Clinical cancer nanomedicine","volume":"25","author":"Wolfram","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0325","unstructured":"Network, N. C. C. (2021)."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208122","article-title":"Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting","volume":"13","author":"Pawar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0335","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","article-title":"A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture","volume":"119","author":"Valente","year":"2017","journal-title":"Acta Histochem."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0340","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1039\/C4CS00034J","article-title":"About supramolecular systems for dynamically probing cells","volume":"43","author":"Brinkmann","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tcb.2020.09.008","article-title":"Mitochondrial fusion: the machineries in and out","volume":"31","author":"Gao","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0350","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201643637","article-title":"The heptad repeat domain 1 of Mitofusin has membrane destabilization function in mitochondrial fusion","volume":"19","author":"Daste","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0355","series-title":"Direct Small Molecule Activation of Mitofusins","first-page":"301713","author":"Zacharioudakis","year":"2018"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0360","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia \u2014 a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/mnfr.200700457","article-title":"From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors","volume":"53","author":"Kurtoglu","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0375","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.7314\/APJCP.2013.14.8.4853","article-title":"Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1\u03b1","volume":"14","author":"Li","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0380","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2867-11-3","article-title":"Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning","volume":"11","author":"Milane","year":"2011","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2011.03.032","article-title":"Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology","volume":"155","author":"Milane","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0390","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pharmtox-010818-021637","article-title":"Targeting of hypoxia-inducible factors","volume":"59","author":"Semenza","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0395","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/cas.12483","article-title":"Kr\u00fcppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells","volume":"105","author":"Zhang","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0400","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0405","doi-asserted-by":"crossref","first-page":"1609802","DOI":"10.3389\/pore.2021.1609802","article-title":"Hypoxia signaling in cancer: from basics to clinical practice","volume":"27","author":"Sebestyen","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152008783961932","article-title":"The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?","volume":"8","author":"L\u00f3pez-L\u00e1zaro","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0415","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0420","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0425","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nano.2010.12.009","article-title":"Pharmacokinetics and biodistribution of lonidamine\/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer","volume":"7","author":"Milane","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0430","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp1002653","article-title":"Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel\/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells","volume":"8","author":"Milane","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024075","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"Milane","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0440","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1369\/jhc.4A6542.2005","article-title":"Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein","volume":"53","author":"Lazarowski","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0445","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2007.03.004","article-title":"Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection?","volume":"258","author":"Lazarowski","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0450","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0455","first-page":"745","article-title":"AEG-1 is associated with hypoxia-induced hepatocellular carcinoma chemoresistance via regulating PI3K\/AKT\/HIF-1alpha\/MDR-1 pathway","volume":"15","author":"Xie","year":"2016","journal-title":"EXCLI J."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0460","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1021\/acsabm.1c00296","article-title":"Transferrin coated d-penicillamine-au-cu nanocluster PLGA nanocomposite reverses hypoxia-induced EMT and MDR of triple-negative breast cancers","volume":"4","author":"Shome","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0465","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0470","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","article-title":"Broad activation of the ubiquitin\u2013proteasome system by Parkin is critical for mitophagy","volume":"20","author":"Chan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0475","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semcdb.2019.05.029","article-title":"Autophagy and mitophagy in cancer metabolic remodelling","volume":"98","author":"Ferro","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0480","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12935-021-02065-w","article-title":"Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics","volume":"21","author":"Guan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0485","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0490","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32866","article-title":"Mfn2 ubiquitination by PINK1\/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy","volume":"7","author":"McLelland","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jconrel.2023.09.023_bb0495","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1","volume":"11","author":"Xiao","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0500","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/cdd.2009.16","article-title":"Role of BNIP3 and NIX in cell death, autophagy, and mitophagy","volume":"16","author":"Zhang","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2023.09.023_bb0505","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923006090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923006090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:51:53Z","timestamp":1759164713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923006090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":101,"alternative-id":["S0168365923006090"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}